China Universal Asset Management Co., Ltd. Collegium Pharmaceutical, Inc Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 6,315 shares of COLL stock, worth $198,038. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,315
Previous 6,838
7.65%
Holding current value
$198,038
Previous $195,000
3.59%
% of portfolio
0.02%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
37.1MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$182 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$94.1 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$82.8 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$70.5 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$51.2 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.07B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...